{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:47:39Z","timestamp":1775040459407,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09581-y","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:35:22Z","timestamp":1772109322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-blinded randomized non-inferiority controlled clinical trial comparing endoscope-assisted flapless approach versus papillary preservation technique in periodontal regeneration of intrabony periodontal defects: study protocol"],"prefix":"10.1186","volume":"27","author":[{"given":"Dominic King Lun","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Rachel","family":"Fok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin Wai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Keung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnson Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Pelekos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"4","key":"9581_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1902\/jop.2002.73.4.374","volume":"73","author":"RV Stambaugh","year":"2002","unstructured":"Stambaugh RV, Myers G, Ebling W, Beckman B, Stambaugh K. Endoscopic visualization of the submarginal gingiva dental sulcus and tooth root surfaces. J Periodontol. 2002;73(4):374\u201382.","journal-title":"J Periodontol"},{"key":"9581_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.14075","author":"KD Ho","year":"2024","unstructured":"Ho KD, Ho KR, Pelekos G, Leung WK, Tonetti MS. Endoscopic re-instrumentation of intrabony defect-associated deep residual periodontal pockets is non-inferior to papilla preservation flap surgery: a randomized trial. J Clin Periodontol. 2024. https:\/\/doi.org\/10.1111\/jcpe.14075.","journal-title":"J Clin Periodontol"},{"issue":"2","key":"9581_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-051X.2008.01352.x","volume":"36","author":"P Cortellini","year":"2009","unstructured":"Cortellini P, Tonetti MS. Improved wound stability with a modified minimally invasive surgical technique in the regenerative treatment of isolated interdental intrabony defects. J Clin Periodontol. 2009;36(2):157\u201363.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"9581_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-051X.2006.01020.x","volume":"34","author":"P Cortellini","year":"2007","unstructured":"Cortellini P, Tonetti MS. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity. J Clin Periodontol. 2007;34(1):87\u201393.","journal-title":"J Clin Periodontol"},{"issue":"4","key":"9581_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1600-051X.2011.01705.x","volume":"38","author":"P Cortellini","year":"2011","unstructured":"Cortellini P, Tonetti MS. Clinical and radiographic outcomes of the modified minimally invasive surgical technique with and without regenerative materials: a randomized-controlled trial in intra-bony defects. J Clin Periodontol. 2011;38(4):365\u201373.","journal-title":"J Clin Periodontol"},{"issue":"8","key":"9581_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1034\/j.1600-051X.2003.00374.x","volume":"30","author":"MA Gutierrez","year":"2003","unstructured":"Gutierrez MA, Mellonig JT, Cochran DL. Evaluation of enamel matrix derivative as an adjunct to non-surgical periodontal therapy. J Clin Periodontol. 2003;30(8):739\u201345.","journal-title":"J Clin Periodontol"},{"issue":"6","key":"9581_CR7","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1007\/s00784-022-04474-1","volume":"26","author":"A Roccuzzo","year":"2022","unstructured":"Roccuzzo A, Imber JC, Stahli A, Kloukos D, Salvi GE, Sculean A. Enamel matrix derivative as adjunctive to non-surgical periodontal therapy: a systematic review and meta-analysis of randomized controlled trials. Clin Oral Investig. 2022;26(6):4263\u201380.","journal-title":"Clin Oral Investig"},{"issue":"2","key":"9581_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jcpe.13074","volume":"46","author":"F Graziani","year":"2019","unstructured":"Graziani F, Gennai S, Petrini M, Bettini L, Tonetti M. Enamel matrix derivative stabilizes blood clot and improves clinical healing in deep pockets after flapless periodontal therapy: A Randomized Clinical Trial. J Clin Periodontol. 2019;46(2):231\u201340.","journal-title":"J Clin Periodontol"},{"issue":"5","key":"9581_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jcpe.13438","volume":"48","author":"HFR Jentsch","year":"2021","unstructured":"Jentsch HFR, Roccuzzo M, Pilloni A, Kasaj A, Fimmers R, Jepsen S. Flapless application of enamel matrix derivative in periodontal retreatment: A multicentre randomized feasibility trial. J Clin Periodontol. 2021;48(5):659\u201367.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"9581_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00784-016-1795-2","volume":"21","author":"M Aimetti","year":"2017","unstructured":"Aimetti M, Ferrarotti F, Mariani GM, Romano F. A novel flapless approach versus minimally invasive surgery in periodontal regeneration with enamel matrix derivative proteins: a 24-month randomized controlled clinical trial. Clin Oral Investig. 2017;21(1):327\u201337.","journal-title":"Clin Oral Investig"},{"issue":"9","key":"9581_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/jcpe.14028","volume":"51","author":"M Aimetti","year":"2024","unstructured":"Aimetti M, Stasikelyte M, Mariani GM, Cricenti L, Baima G, Romano F. The flapless approach with and without enamel matrix derivatives for the treatment of intrabony defects: a randomized controlled clinical trial. J Clin Periodontol. 2024;51(9):1112\u201321.","journal-title":"J Clin Periodontol"},{"issue":"9","key":"9581_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/jcpe.12443","volume":"42","author":"L Nibali","year":"2015","unstructured":"Nibali L, Pometti D, Chen TT, Tu YK. Minimally invasive non-surgical approach for the treatment of periodontal intrabony defects: a retrospective analysis. J Clin Periodontol. 2015;42(9):853\u20139.","journal-title":"J Clin Periodontol"},{"issue":"2","key":"9581_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10038-007-0229-z","volume":"53","author":"SW Shaw","year":"2008","unstructured":"Shaw SW, Chen CP, Cheng PJ, Wang TH, Hou JW, Lin CT, et al. Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome. J Hum Genet. 2008;53(2):136\u201343.","journal-title":"J Hum Genet"},{"key":"9581_CR14","volume-title":"Textbook of Periodontia","author":"S Miller","year":"1938","unstructured":"Miller S. Textbook of Periodontia. Philadelphia, PA: Blakiston Company; 1938."},{"issue":"6","key":"9581_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1034\/j.1600-051X.2003.00013.x","volume":"30","author":"H Wachtel","year":"2003","unstructured":"Wachtel H, Schenk G, Bohm S, Weng D, Zuhr O, Hurzeler MB. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. J Clin Periodontol. 2003;30(6):496\u2013504.","journal-title":"J Clin Periodontol"},{"issue":"4","key":"9581_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1600-0528.1997.tb00941.x","volume":"25","author":"GD Slade","year":"1997","unstructured":"Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997;25(4):284\u201390.","journal-title":"Community Dent Oral Epidemiol"},{"issue":"1","key":"9581_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jcpe.12834","volume":"45","author":"MS Tonetti","year":"2018","unstructured":"Tonetti MS, Cortellini P, Pellegrini G, Nieri M, Bonaccini D, Allegri M. Xenogenic collagen matrix or autologous connective tissue graft as adjunct to coronally advanced flaps for coverage of multiple adjacent gingival recession: randomized trial assessing non-inferiority in root coverage and superiority in oral health-related quality of life. J Clin Periodontol. 2018;45(1):78\u201388.","journal-title":"J Clin Periodontol"},{"issue":"6","key":"9581_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1034\/j.1600-0528.2002.00013.x","volume":"30","author":"MC Wong","year":"2002","unstructured":"Wong MC, Lo EC, McMillan AS. Validation of a Chinese version of the Oral Health Impact Profile (OHIP). Community Dent Oral Epidemiol. 2002;30(6):423\u201330.","journal-title":"Community Dent Oral Epidemiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09581-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:46:35Z","timestamp":1775033195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09581-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9581"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09581-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigator will ensure that this study is conducted in full conformity with the current revision of the Declaration of Helsinki (last amended October 2013). This trial has obtained ethical approval from the Institutional Review Board of The University of Hong Kong\/Hospital Authority Hong Kong West Cluster HKU\/HA HKW IRB (UW25-184, approved 7th May 2025). The trial has been registered at ClinicalTrials.gov (\n                      \n                      ) with the identifier number NCT06147310. Study investigators at the coordinating centre (project management group) meet monthly to review trial progress, including recruitment, protocol adherence, data quality, and safety reports. The PI and data safety coordinator will lead quarterly internal audits of trial conduct, including case report form (CRF) completeness, informed consent documentation, and adverse event reporting, to ensure regulatory compliance, proper documentation, and adherence to Good Clinical Practice (GCP). Oversight is ensured through external representative involvement including data safety coordinator and clinical research centre representative for impartiality. HKU\/HA HKW IRB has the authority to audit studies under their jurisdiction. Adverse events, concurrent procedures, and protocol deviations will be documented and addressed appropriately. Serious adverse events will be reported to the HKU\/HA HKW IRB within 24\u00a0h of notification to the study investigators. Primary data will be stored and retrieved from the IAD-CRC. The participants will be identified by a study-specific participant number and\/or code in the secondary database after retrieving data from the primary database for data analysis. CRF will be in written format with identifiers removed and assigned identifying codes. Codes will be stored in a secure location and separated from data. The name and any other identifying detail will not be included in any secondary study data electronic file. All documents will be stored securely and only accessible by trial staff and authorized personnel. All research-related records (personal and study data) will be retained for 5\u00a0years after study completion. Protocol amendment will be made notified to the funding body by the principal investigator and submitted the protocol amendment form with amended information provided through the Hospital Authority Clinical Research Ethics Review Portal. Upon approval, the revised protocol document will be added to each site\u2019s Investigator Site File (ISF). To ensure compliance across sites, the PI will conduct amendment training sessions with investigators and confirm their acknowledgment of the changes immediately upon IRB approval. In addition, substantive protocol changes will be reflected in the clinical trial registry within 60\u00a0days of IRB approval. A standardized documentation system will be implemented to document protocol deviation. Major deviations will be reported to the IRB within 1 month of identification, while minor deviations will be reported within 3 months, and all instances will be recorded using a formal breach report form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication from subject will be obtained during the informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors reported that there are no known competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}